Antitumor effect of S-1 on DMH induced colon cancer in rats

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1137-1141

  Tsunoda, Akira ^a   Shibusawa, Mikl ^a   Tsunoda, Yuko ^a   Yokoyama, Noboru ^a   Nakao, Kentaroh ^a   Kusano, Mitsuo ^a   Nomura, Naruo ^b   Nagayama, Sekio ^b   Takechi, Teiji ^b  

^a SHOWA UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Barium enema; Colon tumor; Dimethylhydrazine; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; DIMETHYLHYDRAZINE; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031811969     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Shirasaka T, Fukushima M, Shimamoto Y and Kimura K: Preclinical studies on S-1, a new oral tegafur plus modulators: optimal molar ratio and antitumor activity. Proc Int Congr Chemother 18: 927, 1993.
2. Tsunoda A, Shibusawa M, Tsunoda Y, Yasuda N and Koike T: Reduced growth rate of dimethyl-hydrazine -induced colon tumors in rats. Cancer Res 52: 696-700, 1992
3. Tsunoda A, Shibusawa M, Tsunoda Y, Yasuda N, Nakao K and Kusano M: A model for sensitivity determination of anticancer agents against chemically-induced colon cancer in rats. Anticancer Res 14: 2637-2642, 1994.
4. Steel GG: Measurement of tumor size. In: Growth Kinetics of Tumors. Oxford, Clarerdon Press, 1977, pp5-12.
5. Collins VP, Loeffler RK and Tivey H: Observations on growth rates of human tumors. Am J Roentgenol 76: 988-1000, 1956.
6. Jinnai D: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jap J Surg 13: 574-598, 1983.
7. Boven E, Winograd B, Berger DP, Dumont MP, Braakhuis BJM, Fodstad Ø, Langdon S and Fiebig HH: Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Res 52: 5940-5947, 1992.
8. Goldin A and Venditti J M: Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute. Cancer Treat Rep 7: 167-176, 1980.
9. Fujita M and Taguchi T: Application of nude mouse- human cancer xenograft system for sensitivity test of anticancer drugs. Jap J Cancer Chemother 9: 606-615, 1982.
10. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM and Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863-6871, 1988.
11. Mclemore T L, Liu M C, Blacker PC, Gregg M, Alley MC, Abbott B J, Shoemaker RH, Bohlman ME, Litterst CC, Hubbard WC. Brennan RH, Mc-Mahon JB: Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice. Cancer Res 47: 5132-5140, 1987.
12. Vezeridis MP, Doremus CM, Tibbetts LM, Tzanakakis G and Jackson BT: Invasion and metastasis following orthotopic transplantation of human pancreatic cancer in the nude mouse. J Surg Oncol 40: 261-265, 1989.
13. Fujiwara T, Cai DW, Georges RN, Mukhopadhyay T, Grimm EA and Roth JA: Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst 86: 1458-1462, 1994.
14. Alisauskus R, Wong GYC and Gold DV: Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer. Cancer Res (suppl.) 55: 5743s-5748s, 1995.
15. Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, Saito H, Okabe H, Oyama K, Takeda S, Umeki N and Fukushima M: Antitumor activity of 1M tegafur-0.4M 5-chloro-2,4-dihydroxypyridine-1M potassium oxonate(S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 56: 2602-2606, 1996
16. Boyd MR: The future of new drug developmemt. In: J.E. Neiderhuber(ed), Current Therapy in Oncology, Philadelphia, Philadelphia: Decker, BC Inc, 1993, pp11-12.